MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Non-motor Scales"

  • 2025 International Congress

    The Effect of Foslevodopa/Foscarbidopa Treatment on Nonmotor Symptom Burden in Advanced Parkinson’s Disease

    I. Malaty, P. Odin, D. Kern, L. Bergmann, M. Shah, R. Gupta, A. Antonini, K. Chaudhuri (Gainesvile, USA)

    Objective: To investigate the impact of foslevodopa/foscarbidopa (LDp/CDp) on nonmotor symptoms (NMS) in adults with advanced Parkinson’s disease (aPD). Background: LDp/CDp, a 24-hour per day…
  • 2025 International Congress

    The Impact of Bilateral GPi Deep Brain Stimulation on Non-Motor Symptoms in Parkinson’s Disease

    J. Lee, S. Jo, M. Choi, SJ. Chung (Goyang-si, Republic of Korea)

    Objective: This study aimed to evaluate how bilateral Globus Pallidus internus (GPi) Deep Brain Stimulation (DBS) affects non-motor symptoms in individuals diagnosed with Parkinson’s disease…
  • 2025 International Congress

    Modification of Parkinson’s Disease Сourse Using Cell Technologies

    V. Chyzhyk, V. Ponomarev, A. Boika (Minsk, Belarus)

    Objective: To assess the long-term results of the introduction of autologous mesenchymal stem cells (MSCs)  on the intensity of motor and non-motor symptoms and on…
  • 2025 International Congress

    Therapeutic Potential of GLP-1 Receptor Agonists in Parkinson’s Disease: A Systematic Review and Meta-Analysis

    A. Badran, M. Gbreel (Cairo, Egypt)

    Objective: To assess the safety and effectiveness of GLP-1 RAs in patients with PD. Background: Parkinson’s disease (PD) is a progressive neurodegenerative disorder characterized by…
  • 2025 International Congress

    Non-Motor Fluctuations In Parkinson’s Disease: A Cross-Sectional Study On Prevalence, Correlates, And Impact On Quality Of Life

    K. B K, A. Mehta, P. R, M. Javali, L. Priya, P. Acharya (Bengaluru, India)

    Objective: The study aims to assess the prevalence and characteristics of NMF in PD patients in Indian settings and explore their correlation with disease severity,…
  • 2025 International Congress

    Personality Traits and Neuropsychiatric Assessment in De Novo, Clinically Established Body-First and Brain-First Parkinson’s Disease

    P. Antenucci, M. Sensi, V. Resta, L. Spanedda, D. Zecchinato, G. Linzalone, A. Gozzi, L. Zerbinati (Ferrara, Italy)

    Objective: To assess and compare personality profiles and psychiatric symptoms in de-novo clinically-established body-first and brain-first PD. Background: Body-first and brain-first have recently been proposed…
  • 2025 International Congress

    Evaluation of Changes in Non-Motor Symptoms in Parkinson’s Disease Patients: A Twelve-Month Follow-Up After Bilateral Deep Brain Stimulation in the Subthalamic Nucleus

    R. Cong Torres, C. Martínez Cortés, J. Hernández Domínguez, JC. Hernández Rivera, C. Zúñiga Ramírez (Mexico City, Mexico)

    Objective: To determine changes in NMS in PD patients twelve months after undergoing DBS implantation in the STN at the Centro Médico Nacional Siglo XXI…
  • 2025 International Congress

    Interactions between APOE E4 and idiopathic Parkinson’s disease in age-related hearing loss

    M. Kmiecik, M. Mcintyre, B. Nguyen, A. Guan, M. Holmes, S. Aslibekyan (Sunnyvale, USA)

    Objective: Examine the interaction between APOE E4 and idiopathic Parkinson’s disease (PD) on age-related hearing loss using a validated web-based speech-in-noise assessment. Background: Age is…
  • 2025 International Congress

    Prodromal Clinical Markers of Parkinson disease in patients with Gaucher disease and their parents

    WZ. Hu, Q. Yang, Y. Huang (Guangzhou, China)

    Objective: To determine the presence of prodromal markers of Parkinson’s disease (PD) in Gaucher disease (GD) patients and their parents. Background: GBA gene mutation is…
  • 2025 International Congress

    Cognitive Assessment in Parkinson’s Disease: A Mixed Methods Study of Current Neuropsychology Practices in Australia

    J. King, D. Pourzinal, J. Yang, D. Brooks, D. Sriram, K. Sivakumaran, L. Mitchell, N. Dissanayaka (HERSTON, Australia)

    Objective: To investigate the role of neuropsychologists, and their current practices for assessing cognition in Parkinson’s disease (PD). Background: Diagnosis and evaluation of cognitive disorders…
  • 1
  • 2
  • 3
  • …
  • 55
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley